Explore All Access
Check if your research matches the topics covered in ONCOLYTIC VIROTHERAPY?
- Degree of match
- Common matching concepts
- Additional journal recommendations
ONCOLYTIC VIROTHERAPY : Impact Factor & More
eISSN: 2253-1572pISSN: 2253-1572
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
ONCOLYTIC VIROTHERAPY Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in ONCOLYTIC VIROTHERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ONCOLYTIC VIROTHERAPY
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment.
- 1 Feb 2021
- Oncolytic virotherapy
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.
- 1 May 2020
- Oncolytic virotherapy
Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development.
- 1 Mar 2020
- Oncolytic virotherapy
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus.
- 1 Dec 2019
- Oncolytic virotherapy
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
- 1 Oct 2019
- Oncolytic virotherapy
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
- 1 Oct 2019
- Oncolytic virotherapy
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment.
- 1 Feb 2021
- Oncolytic virotherapy
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.
- 1 May 2020
- Oncolytic virotherapy
Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development.
- 1 Mar 2020
- Oncolytic virotherapy
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus.
- 1 Dec 2019
- Oncolytic virotherapy
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
- 1 Oct 2019
- Oncolytic virotherapy
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
- 1 Oct 2019
- Oncolytic virotherapy
FAQs on ONCOLYTIC VIROTHERAPY
How long has ONCOLYTIC VIROTHERAPY been actively publishing? 
ONCOLYTIC VIROTHERAPY has been in operation since 2012 till date.
What is the publishing frequency of ONCOLYTIC VIROTHERAPY?
ONCOLYTIC VIROTHERAPY published with a Continuous publication frequency.
How many articles did ONCOLYTIC VIROTHERAPY publish last year?
In 2023, ONCOLYTIC VIROTHERAPY publsihed undefined articles.
What is the eISSN & pISSN for ONCOLYTIC VIROTHERAPY?
For ONCOLYTIC VIROTHERAPY, eISSN is 2253-1572 and pISSN is 2253-1572.
Who is the publisher of ONCOLYTIC VIROTHERAPY?
DOVE MEDICAL PRESS LTD is the publisher of ONCOLYTIC VIROTHERAPY.